Data Entry: Please note that the research database will be replaced by UNIverse by the end of October 2023. Please enter your data into the system https://universe-intern.unibas.ch. Thanks

Login for users with Unibas email account...

Login for registered users without Unibas email account...

 
Prognostic biomarkers in primary progressive multiple sclerosis: validating and scrutinizing multimodal evoked potentials
JournalArticle (Originalarbeit in einer wissenschaftlichen Zeitschrift)
 
ID 4651609
Author(s) Hardmeier, M.; Schlaeger, R.; Lascano, A. M.; Toffolet, L.; Schindler, C.; Gobbi, C.; Lalive, P.; Kuhle, J.; Kappos, L.; Fuhr, P.
Author(s) at UniBasel Schindler, Christian
Year 2022
Title Prognostic biomarkers in primary progressive multiple sclerosis: validating and scrutinizing multimodal evoked potentials
Journal Clinical neurophysiology
Volume 137
Pages / Article-Number 152-158
Keywords Biomarker; Clinical trial design; Evoked Potentials; Prognosis; Progressive Multiple Sclerosis; Quantitative EP Score; competing financial interests or personal relationships that could have appeared; to influence the work reported in this paper.
Mesh terms Biomarkers; Disability Evaluation; Disease Progression; Evoked Potentials, physiology; Humans; Multiple Sclerosis; Multiple Sclerosis, Chronic Progressive, diagnosis; Prognosis
Abstract OBJECTIVE: To validate the prognostic value of multimodal evoked potentials (mmEP) in primary progressive multiple sclerosis (PPMS) and to determine the most predictive EP-modalities. METHODS: Thirty-nine patients with PPMS (expanded disability status scale (EDSS): 2.0-6.5; mean clinical follow-up: 2.8 years) had visual (VEP), upper and lower limb somatosensory (SEP) and motor EP (MEP) at baseline. Quantitative EP-scores for single (qVEP, qSEP, qMEP) and combined modalities were correlated to EDSS and compared to previously published data of 21 PPMS patients. Predictors of EDSS-change were analyzed in pooled data by linear regression. RESULTS: Samples were comparable. Except qVEP, all EP-scores were correlated to EDSS at baseline (Rho: 0.45-0.69; p < 0.01) and follow-up (Rho: 0.59-0.80; p < 0.001). Combined EP-modalities significantly predicted EDSS-change (R(2)adj: 0.24), while EDSS and age did not. Tibial qSEP (R(2)adj: 0.22) and qMEP (R(2)adj: 0.26) were the best single modality predictors, outperformed by their combination (R(2)adj: 0.32). CONCLUSIONS: Quantitative EP-scores predict up to 32% of EDSS-change over three years. Modalities representing motor and long tract function carry the main prognostic information. SIGNIFICANCE: Replication of previous results corroborates the use of mmEP as a prognostic biomarker candidate in PPMS.
ISSN/ISBN 1388-2457
URL https://doi.org/10.1016/j.clinph.2022.02.019
edoc-URL https://edoc.unibas.ch/90529/
Full Text on edoc Available
Digital Object Identifier DOI 10.1016/j.clinph.2022.02.019
PubMed ID http://www.ncbi.nlm.nih.gov/pubmed/35316624
ISI-Number WOS:000791223500017
Document type (ISI) Journal Article
 
   

MCSS v5.8 PRO. 0.336 sec, queries - 0.000 sec ©Universität Basel  |  Impressum   |    
15/06/2024